No Data
No Data
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
Express News | PMV Pharmaceuticals Inc Files for Mixed Shelf of up to $200 Mln – SEC Filing
Oppenheimer Upgrades PMV Pharmaceuticals(PMVP.US) to Buy Rating, Announces Target Price $6
PMV Pharmaceuticals Upgraded to Outperform From Perform at Oppenheimer
TD Cowen Maintains PMV Pharmaceuticals(PMVP.US) With Buy Rating
Optimistic Buy Rating for PMV Pharmaceuticals Driven by Strategic Clinical Trials and Strong Financial Position
Unlock the Full List